Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics
Abstract The glutathione (GSH) redox system plays a central role in maintaining cellular homeostasis, but its dysregulation in cancer contributes to tumor progression, therapy resistance, and metabolic adaptation. Elevated intracellular GSH levels represent both a barrier to conventional therapies a...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer
2026-02-01
|
| Col·lecció: | Discover Oncology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/s12672-026-04456-9 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|